Antidepressants work by changing the levels of chemical messengers in your brain, primarily serotonin, norepinephrine, and dopamine. These chemicals carry signals between brain cells, and when their levels drop too low or their signaling becomes disrupted, mood, sleep, energy, and motivation can all suffer. Different types of antidepressants target this problem in different ways, but they all aim to restore more normal chemical signaling. The process isn’t instant: while the chemical changes begin within hours, meaningful mood improvement typically takes two to six weeks.
Chemical Messengers and the Synapse
To understand antidepressants, it helps to know what happens when two brain cells communicate. One cell releases chemical messengers (called neurotransmitters) into the tiny gap between it and the next cell. The receiving cell picks up the signal. Then, normally, the sending cell reabsorbs the leftover chemical through a process called reuptake, essentially recycling it.
In depression, this system can go wrong. The recycling process may pull chemicals back too quickly, or the cells may not produce enough in the first place. The result is that fewer signals get through, and the brain circuits responsible for mood, motivation, and pleasure don’t fire the way they should. Most antidepressants intervene somewhere in this cycle, either slowing down the recycling or preventing the breakdown of these chemicals.
SSRIs: The Most Common Type
Selective serotonin reuptake inhibitors are the most widely prescribed antidepressants. They work by blocking the reuptake of serotonin specifically. After serotonin carries a signal between brain cells, it would normally get pulled back into the sending cell. SSRIs block that process, leaving more serotonin available in the gap to keep passing messages. This selectivity for serotonin (rather than other brain chemicals) is what makes them “selective,” and it’s also why they tend to cause fewer side effects than older antidepressants that affect multiple chemical systems at once.
SNRIs: Targeting Two Chemicals
Serotonin-norepinephrine reuptake inhibitors do the same thing SSRIs do, but for two neurotransmitters instead of one. They block the reabsorption of both serotonin and norepinephrine, a chemical involved in alertness, energy, and concentration. This dual action can help with a wider range of symptoms, which is why SNRIs are sometimes chosen when fatigue, poor concentration, or physical pain symptoms accompany depression. They’re often used as a second option if SSRIs alone aren’t enough.
Older Medications: TCAs and MAOIs
Before SSRIs and SNRIs, two older classes of antidepressants were the standard treatment. They still get prescribed today, usually when newer options haven’t worked.
Tricyclic antidepressants (TCAs) block the reuptake of serotonin and norepinephrine, similar to SNRIs. But they also interact with other receptor systems in the brain, including those involved in histamine signaling and the body’s fight-or-flight response. This broader action means they can be effective, but it also produces more side effects like drowsiness, dry mouth, and weight gain.
MAOIs take an entirely different approach. Instead of blocking recycling, they block an enzyme called monoamine oxidase, whose job is to break down serotonin, norepinephrine, and dopamine. By preventing the enzyme from destroying these chemicals, MAOIs allow their levels to build up in the brain. They can be highly effective, but they require dietary restrictions because the same enzyme that breaks down neurotransmitters also breaks down a compound found in aged cheeses, cured meats, and fermented foods. Without that enzyme working normally, eating those foods can cause dangerous spikes in blood pressure.
Why Improvement Takes Weeks
This is one of the most common questions people have, and it’s a fair one. If antidepressants change brain chemistry within hours, why does it take weeks to feel better? The answer involves something deeper than neurotransmitter levels alone.
The initial boost in serotonin or norepinephrine is just the first step. What actually seems to lift depression is a slower process: the brain gradually rewires itself. Chronic antidepressant treatment promotes the growth of new brain cells in a region called the hippocampus, which is involved in mood regulation and memory. Research in the Journal of Neuroscience found that several different classes of antidepressants increase the birth of new neurons in this area, and that this only happens with sustained treatment, not a single dose. This timeline matches the clinical reality that most people start noticing improvement around week two, with fuller effects building over four to six weeks.
Depression itself appears to cause shrinkage and cell loss in the hippocampus. So one way to think about the weeks-long delay is that antidepressants aren’t just topping off a chemical tank. They’re helping the brain physically rebuild structures that stress and depression have damaged. Some measurable improvement in symptoms can appear as early as the first week, but results vary from person to person, and meaningful, stable improvement generally takes longer.
How Effective They Are
Antidepressants work better than a placebo, but they don’t work for everyone. The standard measure in clinical trials is whether someone’s symptom score drops by at least 50%. Across large trials, antidepressants consistently outperform placebo on this measure, with the difference becoming statistically significant by the second week of treatment. However, placebo response rates in depression trials are also substantial, which means some people improve regardless of whether they’re taking the active medication. This doesn’t mean the drugs are useless. It means depression responds to multiple factors: the medication itself, the structure of being in treatment, and the natural fluctuation of the illness.
In practice, most people try one or two medications before finding one that works well for them. This trial-and-error process is partly because each person’s brain chemistry is slightly different.
Genetic Differences in Drug Response
Your genes influence how quickly your body processes antidepressants. A family of liver enzymes is responsible for breaking down most of these medications, and genetic variations determine how active those enzymes are in your body. Some people are “ultrarapid metabolizers,” meaning the drug leaves their system too fast to work properly and they may need higher doses. Others are “poor metabolizers” who break the drug down slowly, allowing it to build up and potentially cause stronger side effects at standard doses.
Genetic testing for these enzyme variations is available and increasingly used. A simple test can reveal whether you’re likely to process a given medication faster or slower than average, helping your prescriber choose the right drug and dose with less guesswork. It doesn’t guarantee the medication will work for your depression, but it can reduce the chance that you’ll spend weeks on a dose that was never going to be right for your body.
Risks in Children and Adolescents
Antidepressants carry a specific safety concern for younger patients. An FDA analysis of 24 clinical trials covering more than 4,400 children and adolescents found that those taking antidepressants had about a 4% rate of increased suicidal thinking or behavior during the first few months of treatment, compared to 2% for those taking a placebo. This led the FDA to require a boxed warning on all antidepressant packaging.
The risk is highest during the first few months and during any dose changes. For young people starting antidepressants, close monitoring matters: daily observation by family members and frequent check-ins with the prescriber. This doesn’t mean antidepressants should never be used in this age group. It means the decision requires weighing the risk of suicidality against the very real harm of untreated depression, and that early weeks of treatment need careful attention.
Common Side Effects
Side effects vary by medication class, but some patterns are consistent. SSRIs and SNRIs commonly cause nausea, headache, and sleep disruption in the first week or two, which often fades as the body adjusts. Sexual side effects, including reduced desire and difficulty with arousal or orgasm, are more persistent and affect a significant number of people on these medications. Weight changes can go in either direction depending on the specific drug.
Older antidepressants like TCAs tend to cause more sedation, dry mouth, constipation, and weight gain because of their broader chemical effects. MAOIs carry the additional burden of dietary restrictions. For most people, the newer medications are tried first precisely because their side effect profile is narrower, even if no antidepressant is side-effect free.